Drug manufacturer GlaxoSmithKline has settled lawsuits regarding the diabetes drugs Avandamet and Avandia, according to the United States Department of Justice. Takeda Pharmaceutical has settled lawsuits regarding the diabetes drug Actos, notes Bloomberg.
GlaxoSmithKline settled lawsuits with state and federal governments regarding the diabetes drug Avandamet in 2010, notes the United States Department of Justice. The lawsuits alleged that the company made false claims regarding the purity of Avandamet and other drugs that were manufactured at a plant in Puerto Rico.
GlaxoSmithKline settled lawsuits in 2012 regarding their misrepresentation of the diabetes drug Avandia, as well as other drugs. Charges in the Avandia lawsuit asserted that the drug company falsely claimed that Avandia had a positive cholesterol profile and offered cardiovascular benefits. GlaxoSmithKline agreed to a settlement of $508 million with the federal government, and $149 million in combined state settlements regarding Avandia.
In 2015, Takeda Pharmaceutical agreed to settlements totaling $2.3 billion to resolve lawsuits regarding its diabetes drug Actos, as well as claims that the company had hidden cancer risks associated with taking the drug, notes Bloomberg. The company lost a similar lawsuit in 2014 in which the plaintiff claimed that Actos had caused his bladder cancer. Five other juries have found Takeda Pharmaceutical liable for injuries related to Actos, and there were several thousand lawsuits pending against the company based on harm caused by the drug, as of March 2015.